Effects of protein kinase C activators on phorbol ester-sensitive and -resistant EL4 thymoma cells

Carcinogenesis

Volumn 18, Issue 9, 1997, Pages 1817-1824

  Sansbury, Heather M ^a   Wisehart Johnson, April E ^a   Qi, Chen ^a   Fulwood, Sandra ^a   Meier, Kathryn E ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 2; MITOGEN ACTIVATED PROTEIN KINASE; PHORBOL 13 ACETATE 12 MYRISTATE; PHORBOL ESTER; PROTEIN KINASE C; PROTEIN KINASE C ACTIVATOR;

ANIMAL CELL; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; MOUSE; NONHUMAN; ONCOGENE C JUN; PHENOTYPE; PRIORITY JOURNAL; THYMOMA;

ANIMALS; BIOLOGICAL TRANSPORT; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; DRUG RESISTANCE, NEOPLASM; ENZYME ACTIVATION; MICE; PROTEIN KINASE C; RIBOSOMAL PROTEIN S6 KINASES; TETRADECANOYLPHORBOL ACETATE; THYMOMA; TUMOR CELLS, CULTURED;

EID: 0031427717     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/18.9.1817     Document Type: Article

References (39)

1. Harrison, J.R., Lynch, K.R. and Sando, J.J. (1987) Phorbol esters induce interleukin 2 mRNA in sensitive but not in resistant EL4 cells. J. Biol. Chem., 262, 234-238.
2. Sando, J.J., Hilfiker, M.L., Piacentinin, M.J. and Laufer, T.M. (1982) Identification of phorbol ester receptors in T-cell growth factor-producing and -non-producing EL4 mouse thymoma cells. Cancer Res., 42, 1676-1680.
3. Davis, R.J. (1993) The mitogen-activated protein kinase signal transduction pathway. J. Biol. Chem., 268, 14553-14556.
4. Meier, K.E., Licciardi, K.A., Haystead, T.A.J. and Krebs, E.G. (1991) Activation of messenger-independent protein kinases in wild-type and phorbol ester-resistant EL4 thymoma cells. J. Biol. Chem., 256, 1914-1920.
5. Gause, K.C., Homma, M.K., Licciardi, K.A., Seger, R., Ahn, N.G., Peterson, M.J., Krebs, E.G. and Meier, K.E. (1993) Effects of phorbol ester on mitogen-activated protein kinase kinase activity in wild-type and phorbol ester-resistant EL4 thymoma cells. J. Biol. Chem., 268, 16124-16129.
6. Cohen, P., Holmes, C.F.B. and Tsukitani, Y. (1990) Okadaic acid: a new probe for the study of cellular regulation. TIBS, 15, 98-102.
7. Cobb, M.H. and Goldsmith, E.J. (1995) How MAP kinases are regulated. J. Biol. Chem., 270, 19828-19832.
8. Su, B., Jacinto, E., Hibi, M., Kallunki, T., Karin, M. and Ben-Neriah, Y. (1994) JNK is involved in signal integration during costimulation of T lymphocytes. Cell, 77, 727-736.
9. Jain, J., Loh, C. and Rao, A. (1995) Transcriptional regulation of the IL-2 gene. Curr. Opin. Cell Biol., 1, 333-342.
10. Jensen, D.E., Frankis, R.C. and Sando, J.J. (1991) Defective induction of Jun and Fos-related proteins in phorbol ester-resistant EL4 mouse thymoma cells. Oncogene, 6, 1219-1225.
11. Karin, M. (1995) The regulation of AP-1 activity by mitogen-activated protein kinases. J. Biol Chem., 270, 16483-16486.
12. Kyriakis, J.M., Banerjee, P., Nikolakaki, E., Dai, T., Rubie, E.A., Ahmad, M.F., Avruch, J. and Woodgett, J.R. (1994) The stress-activated protein kinase subfamily of c-Jun kinases. Nature, 369, 156-160.
13. Minden, A., Lin, A., McMahon, M., Lange-Carter, C., Derrijard, B., Davis, R.J., Johnson, G.L. and Karin, M. (1994) Differential activation of ERK and JNK mitogen-activated protein kinase by Raf-1 and MEKK. Science, 266, 1719-1723.
14. ras, Raf-1. and MAP kinase kinase. J. Biol. Chem., 269, 31836-31844.
15. Minden, A., Lin, A., Claret, F.-X., Abo, A. and Karin, M. (1995) Selective activation of the JNK signaling cascade and c-Jun transcriptional activity by the small GTPases Rac and Cdc42Hs. Cell, 81, 1147-1157.
16. Coso, O.A., Chiariello, M., Yu, J.-C., Teramoto, H., Crespo, P., Xu, N., Miki, T. and Gutkind, J.S. (1995) The small GTP-binding proteins Rac1 and Cdc42 regulate the activity of the JNK/SAPK signaling pathway. Cell, 81, 1137-1146.
17. Lei, W., Whaley, C.D., Mondino, A. and Mueller, D.L. (1996) Blocked signal transduction to the ERK and JNK protein kinases in anergic CD4+ T cells. Science, 271, 1272-1276.
18. Fields, P.E., Gajewski, T.F. and Fitch, F.W. (1996) Blocked ras activation in anergic CD4+ T cells. Science, 271, 1276-1278.
19. Alberola-Ila, J., Forbush, K.A., Seger, R., Krebs, E.G. and Perlmutter, R.M. (1995) Selective requirement for MAP kinase activation in thymocyte differentiation. Nature, 373, 620-623.
20. Slaga, T.J., Fisher, S.M., Nelson, K. and Gleason, G.L. (1980) Studies on mechanism of action of anti-tumor-promoting agents: their specificity in two-stage promotion. Proc. Natl Acad. Sci. USA, 77, 3659-3663.
21. Ryves, W.J., Evans, A.T., Olivier, A.R., Parker, P.J. and Evans, F.J. (1991) Activation of the PKC-isotypes alpha, beta 1, gamma, delta and epsilon by phorbol esters of different biological activities. FEBS Lett., 288, 5-9.
22. Szallasi, Z., Denning, M.F., Smith, C.B., Dlugosz, A.A., Yuspa, S.H., Pettit, G.R. and Blumberg, P.M. (1994) Differential regulation of protein kinase C isozymes by bryostatin 1 and phorbol 12-myristate 13-acetate in NIH 3T3 fibroblasts. Mol. Pharm., 46, 840-850.
23. Chavin, K.D., Qin, L., Woodward, J.E., Baliga, P. and Bromberg, J.S. (1993) Combination anti-CD2 and anti-CD3 monoclonal antibodies induce tolerance while altering interleukin-2, interleukin-4, tumor necrosis factor, and transforming growth factor-beta production. Ann. Surg., 218, 492-503.
24. Bradshaw, C.D., Ella, K.M., Qi, C., Sansbury, H.M., Wisehart-Johnson, A.E. and Meier, K.E. (1996) Effects of phorbol ester on phospholipase D and mitogen-activated protein kinase activities in T-lymphocyte cell lines. Immun. Lett., 53, 69-76.
25. Farrar, J.J., Fuller-Farrar, J., Simon, P.L., Hilfiker, M.L., Stadler, B.M. and Farrar, W.L. (1980) Thymoma production of T cell growth factor (interleukin 2). J. Immunol., 125, 2555-2558.
26. Desrivieres, S., Volarevic, S., Mercep, L. and Ferrari, S. (1997) Evidence for different mechanisms of growth inhibition of T-cell lymphoma by phorbol esters and concanavalin A. J. Biol. Chem., 272, 2470-2476.
27. Knoepp, S.M., Wisehart-Johnson, A.E., Buse, M.G., Ella, K.M., Bradshaw, C.D. and Meier, K.E. (1996) Synergistic effects of insulin and phorbol ester on mitogen-activated protein kinase in Rat-1 HIR cells. J. Biol. Chem., 271, 1678-1686.
28. Alessi, D.R., Cuenda, A., Cohen, P., Dudley, D.T. and Saltiel, A.R. (1995) PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J. Biol. Chem., 270, 27489-27494.
29. Bradshaw, C.D., Ella, K.M., Thomas, A.L., Qi, C. and Meier, K.E. (1996) Effects of Ara-C on neutral sphingomyelinase and mitogen-and stress-activated protein kinases in T-lymphocyte cell lines. Biochem. Mol. Biol. Intl, 40, 709-719.
30. Kiley, S.C., Parker, P.J., Fabbro, D. and Jaken, S. (1992) Selective redistribution of protein kinase C-epsilon by thapsigargin and staurosporine. Carcinogenesis, 13, 1997-2001.
31. Roivainen, R. and Messing, R.O. (1993) The phorbol derivatives thymeleatoxin and 12-deoxyphorbol-13-O-phenylacetate-10-acetate cause translocation and down-regulation of multiple protein kinase C isozymes. FEBS Lett., 319, 31-34.
32. Huwiler, A., Fabbro, D. and Pfeilschifter, J. (1994) Comparison of different tumour promoters and bryostation 1 on protein kinase C activation and down-regulation in rat renal mesangial cells. Biochem. Pharmacol., 48, 689-700.
33. MacDonald, I., Knox, K.A. and Gordon, J. (1994) Stimulation of human B lymphocytes by phorbol esters reported to be selective in the protein kinase C isoforms they activate. Mol. Immunol., 31, 671-674.
34. Marks, F., Bertsch, S. and Furstenberger, G. (1979) Ornithine decarboxylase activity, cell proliferation, and tumor promotion in mouse epidermis in vivo. Cancer Res., 39, 4183-4188.
35. Osada, S., Mizumo, K., Saido, T.C., Akita, Y., Suzuki, K., Kuroki, T. and Ohno, S. (1990) A phorbol ester receptor/protein kinase, nPKC eta, a new member of the protein kinase C family predominately expressed in lung and skin. J. Biol. Chem., 265, 22434-22440.
36. Wang, S.-J., Warren, B.S., Rupp, T., Beltran, L.M. and DeGiovanni, J. (1994) Loss of mouse epidermal protein kinase C isozyme activities following treatment with phorbol ester and non-phorbol ester tumor promoters. Carcinogenesis, 15, 2795-2803.
37. Xia, Z., Dickens, M., Rainegeaud, J., Davis, R.J. and Greenberg, M.E. (1995) Opposing effects of ERK and JUN-p38 MAP kinases on apoptosis. Science, 270, 1326-1331.
38. Zheng, B., Chambers, T.C., Raynor, R.L., Markham, P.N., Gebel, H.M., Vogler, W.R. and Kuo, J.F. (1994) Human leukemia K562 cell mutant (K562/OA200) selected for resistance to okadaic acid (protein phosphatase inhibitor) lacks protein kinase C-epsilon, exhibits multidrug resistance phenotype, and expresses drug pump P-glycoprotein. J. Biol. Chem., 269, 12332-12338.
39. Alessandrini, A., Greulich, H., Huang, W. and Erikson, R.L. (1996) Mek1 phosphorylation site mutants activate Raf-1 in NIH 3T3 cells. J. Biol. Chem., 271, 31612-31618.